SP1 and gastric cancer: Furthermore, in cisplatin-resistant gastric cancer tissues, it was found that low-SUMOylation of SP1 increased the expression of SP1 in gastric cancer tissues, and the increased SP1 promoted drug resistance of gastric cancer cells through the SNHG17/miR-23b-3p/Notch2 axis [22].